By Marisa Olson
NDCR 2009 by Daniel A. Hussar, P'62, MS'64, PhD'67, Remington professor of pharmacy, provides a first-of-its-kind reference for pharmacists and healthcare practitioners. Published by Moore Road Press, NDCR 2009 details the 158 new drugs that have been marketed in the U.S. during the 2002–2008 period and features comparisons to previously marketed drugs, specific advantages and disadvantages of each, and ratings for each new drug based on comparisons with related agents.
 |
To provide an unbiased and comparative analysis of the new drugs marketed each year, Dr. Hussar uses the New Drug Comparison Rating (NDCR) system, a one-to-five point scale he created to succinctly rate a drug’s importance based on comparisons with related agents.
Dr. Sarah M. Wieczorkiewicz, clinical assistant professor at the University of Illinois at Chicago College of Pharmacy called NDCR 2009 “an invaluable reference for pharmacists,” while Dr. Tim R. Covington, president and CEO of Covington Healthcare Associates said the text presents the “most relevant information about new drugs in a format that is easy to read and comprehend. Any consumer, health professional, insurer/managed care organization, or enterprise that objectively evaluates drug therapy could benefit from the content of this book.”
For more information or to order this valuable reference, please visit www.newdrugsndcr.com.
Comments